Discrimination between neurochemical and macromolecular signals in human frontal lobes using short echo time proton magnetic resonance spectroscopy.
暂无分享,去创建一个
John S Duncan | Gareth J Barker | G. Barker | J. Duncan | M. McLean | R. Simister | Mary A McLean | Robert J Simister
[1] G J Barker,et al. Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.
[2] U. Klose,et al. Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.
[3] K. Behar,et al. Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.
[4] G. Barker,et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy , 1993, The Lancet.
[5] J S Duncan,et al. Short echo time single‐voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging–negative temporal lobe epilepsy: Different biochemical profile compared with hippocampal sclerosis , 1999, Annals of neurology.
[6] K. Behar,et al. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain , 1996, Magnetic resonance in medicine.
[7] C Gössl,et al. Improved analysis of 1H‐MR spectra in the presence of mobile lipids , 2001, Magnetic resonance in medicine.
[8] Wolfgang Grodd,et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.
[9] Jullie W Pan,et al. 2D 1H spectroscopic imaging of the human brain at 4.1 T , 1994, Magnetic resonance in medicine.
[10] U Klose,et al. Elimination of residual lipid contamination in single volume proton MR spectra of human brain. , 1999, Magnetic resonance imaging.
[11] John S Duncan,et al. A Proton Magnetic Resonance Spectroscopy Study of Metabolites in the Occipital Lobes in Epilepsy , 2003, Epilepsia.
[12] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[13] Michael Erb,et al. Proton magnetic resonance spectroscopy with metabolite nulling reveals regional differences of macromolecules in normal human brain , 2002, Journal of magnetic resonance imaging : JMRI.
[14] I. Fried,et al. In vivo measurements of glutamine+ glutamate (Glx) and N‐acetyl aspartate (NAA) levels in human partial epilepsy , 2000, Acta neurologica Scandinavica.
[15] J. Slotboom,et al. Quantitative 1H‐magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model‐fitting , 2002, Magnetic resonance in medicine.
[16] Roland Kreis,et al. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.
[17] R. Mattson,et al. Initial Observations on Effect of Vigabatrin on In Vivo 1H Spectroscopic Measurements of γ‐Aminobutyric Acid, Glutamate, and Glutamine in Human Brain , 1995, Epilepsia.
[18] J. Knight‐Scott,et al. Application of multiple inversion recovery for suppression of macromolecule resonances in short echo time (1)H NMR spectroscopy of human brain. , 1999, Journal of magnetic resonance.
[19] Wolfgang Grodd,et al. Proton MRS in Kennedy disease: Absolute metabolite and macromolecular concentrations , 2002, Journal of magnetic resonance imaging : JMRI.
[20] B J Soher,et al. Automated spectral analysis II: Application of wavelet shrinkage for characterization of non‐parameterized signals , 1998, Magnetic resonance in medicine.
[21] G B Matson,et al. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability. , 2001, Magnetic resonance imaging.
[22] U Klose,et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.